$3250 | Single User
$4650 | Site License
$5650 | Global License

Intravenous Immunoglobulin Market, By Disease Types (CIDP, Hypogammaglobulinemia, Congenital AIDS, Immunodeficiency diseases, Chronic Lymphocytic Leukaemia, Myasthenia Gravis, Multifocal motor neuropathy, and others), By Route (Intravenous and Subcutaneous) And Geography (North America, Europe, Asia Pacific, And Rest Of The World) – Analysis, Share, Trends, Size, & Forecast From 2016 – 2027- C
[Lowest Price Guaranteed: $3,250]

Published by AnalystView: 01 Jul 2020 | 270587 | In Stock
Related Topics: COVID , FDA , Leukemia

Introduction

REPORT HIGHLIGHT

The intravenous immunoglobulin market is estimated to represent a global market of USD 8,306 million by 2019 with growth rate of 6.3%. Intravenous immunoglobulin (IVIG) is an antibody-based product that can be administered intravenously. It contains the pooled immunoglobulin G, derived from the plasma. In terms of types, these products are categorized as immunoglobulin A, immunoglobulin G, immunoglobulin M, immunoglobulin D, and immunoglobulin E, divided based on the variety of heavy chain these molecules contain. IVIG therapy is basically indicated to the patients with humoral immunodeficiency or whose body does not produce enough antibodies. IVIG therapy act by providing extra antibodies which last for several weeks and help patients to fight against various infectious diseases. Alternatively, the immunoglobulin therapy can provide through subcutaneous route (as an injection under the skin) or intramuscular route.

Market Dynamics

Intravenous Immunoglobulin (IVIG) and Subcutaneous Immunoglobulin (SCIG) are preferred for treatment of autoimmune diseases. The growth of this market is primarily attributed to the increasing incidences bleeding and autoimmune disorders, aging population, and development of new treatment indications such as myasthenia gravis. However, high cost coupled with stringent regulations associated with IVIG therapy hampers the market growth over the future period.

COVID-19 Impact

The proposed reports analyse and evaluates the COVID-19 impact, and anticipated change on the future market scenario on this industry, by taking into the account the economic, political, technological, and social, parameters.

Disease Types Takeaway

IVIG therapy is widely used for the treatment of many autoimmune diseases. Based on the disease types, the market is divided as Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Hypogammaglobulinemia, Congenital AIDS, Immunodeficiency diseases, Chronic Lymphocytic Leukemia, Myasthenia Gravis, Multifocal motor neuropathy, and others. In 2019, Hypogammaglobulinemia is considered to be the largest market, accounted for the 1.6 billion during the same year. It is an immune disorder, characterized by the low level of immunoglobulin and mature B-lymphocytes and plasma cells. This condition can be treated by the replacement of immunoglobulin by subcutaneous or intravenous therapies with antibiotics. IVIG therapy for the treatment of Congenital AIDS is growing significantly, i.e. 7.9% over the forecast period. In terms of route of administration, intravenous route of administration captured the largest share of the total market, around 80.1% in 2019.

Regional Takeaway

Regionally, North America is considered to be the major market, capturing around 47% share across the year owing to the rise in the incidence of autoimmune diseases. According to the American Autoimmune Related Disease Association, Inc. (AARDA), about 50 million Americans were suffered from autoimmune diseases in the year 2012 and the number is expected to grow over the forecast period.

Developing regions such as Asia Pacific, and Latin America is accounted for the significant revenue share due to the favourable government initiatives. For example, in September 2013, Japanese Ministry of Health, Labour and Welfare have approved Hizentra, subcutaneous immunoglobulin therapy.

Key Vendor Takeaway

Companies such as Shire, Octapharma, CSL. Grifols and others are profiled in a study. Increasing research and development initiatives coupled with growing revenue generation from IVIG business by leading players have attracted many companies to invest in this market. For example, CSL recorded around USD 2,320 million from its immunoglobulin business segment in 2014, up 12% compared to the previous year.

In March 2010, the U.S. FDA approved Hizentra, company’s subcutaneous immunoglobulin product which has contributed strong sale in the U.S. and European market. Strong growth is majorly attributed to its convenience in self-administration along with the introduction of co-pay relief program. In addition to this, the recent approval of Hizentra for treatment of primary and secondary immune deficiencies in Japan coupled with the expansion of bi-weekly administration label in the U.S. market has supported the revenue generation. Furthermore, the company achieved strong growth with Privigen and Carimune sale in the Europe and America respectively.

The market size and forecast for each segment has been provided for the period 2016 to 2027, considering 2019 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2021 to 2027 for every reported segment.

The years considered for the study are:

Historical Year – 2016 to 2018

Base Year – 2019

Estimated Year – 2020

Projected Year – 2027

Table of Contents
for Intravenous Immunoglobulin Market, By Disease Types (CIDP, Hypogammaglobulinemia, Congenital AIDS, Immunodeficiency diseases, Chronic Lymphocytic Leukaemia, Myasthenia Gravis, Multifocal motor neuropathy, and others), By Route (Intravenous and Subcutaneous) And Geography (North America, Europe, Asia Pacific, And Rest Of The World) – Analysis, Share, Trends, Size, & Forecast From 2016 – 2027- C

  • TABLE OF CONTENT

    1. INTRAVENOUS IMMUNOGLOBULIN MARKET OVERVIEW

    1.1. Study Scope

    1.2. Base Year

    1.3. Assumption and Methodology

    2. EXECUTIVE SUMMARY

    2.1. Key Market Facts

    2.2. Geographical Scenario

    2.3. Companies in the Market

    3. INTRAVENOUS IMMUNOGLOBULIN KEY MARKET TRENDS

    3.1. Market Drivers

    3.1.1. Impact Analysis of Market Drivers

    3.2. Market Restraints

    3.2.1. Impact Analysis of Market Restraints

    3.3. Market Opportunities

    3.4. Market Future Trends

    4. INTRAVENOUS IMMUNOGLOBULIN INDUSTRY STUDY

    4.1. Company Activity Analysis

    4.2. Regulatory Framework Analysis

    4.3. Market Attractiveness Analysis

    4.4. Value Chain Analysis

    5. INTRAVENOUS IMMUNOGLOBULIN MARKET LANDSCAPE

    5.1. Market Share Analysis

    5.2. Key Innovators

    6. INTRAVENOUS IMMUNOGLOBULIN MARKET – BY DISEASE TYPES:

    6.1. Overview

    6.2. CIDP

    6.2.1. Overview

    6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    6.3. Hypogammaglobulinemia

    6.3.1. Overview

    6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    6.4. Congenital AIDS

    6.4.1. Overview

    6.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    6.5. Immunodeficiency diseases

    6.5.1. Overview

    6.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    6.6. Chronic Lymphocytic Leukaemia

    6.6.1. Overview

    6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    6.7. Myasthenia Gravis

    6.7.1. Overview

    6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    6.8. Multifocal motor neuropathy

    6.8.1. Overview

    6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    6.9. Others

    6.9.1. Overview

    6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    7. INTRAVENOUS IMMUNOGLOBULIN MARKET – BY ROUTE OF ADMINISTRATION:

    7.1. Overview

    7.2. Intravenous

    7.2.1. Overview

    7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    7.3. Subcutaneous

    7.3.1. Overview

    7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    8. INTRAVENOUS IMMUNOGLOBULIN MARKET– BY GEOGRAPHY

    8.1. Introduction

    8.2. North America

    8.2.1. Overview

    8.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    8.2.3. U.S.

    8.2.3.1. Overview

    8.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    8.2.4. Canada

    8.2.4.1. Overview

    8.2.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    8.3. Europe

    8.3.1. Overview

    8.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    8.3.3. France

    8.3.3.1. Overview

    8.3.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    8.3.4. Germany

    8.3.4.1. Overview

    8.3.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    8.3.5. Rest of Europe

    8.3.5.1. Overview

    8.3.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    8.4. Asia Pacific (APAC)

    8.4.1. Overview

    8.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    8.4.3. China

    8.4.3.1. Overview

    8.4.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    8.4.4. India

    8.4.4.1. Overview

    8.4.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    8.4.5. Rest of APAC

    8.4.5.1. Overview

    8.4.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    8.5. Rest of the World

    8.5.1. Overview

    8.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    8.5.3. Latin America

    8.5.3.1. Overview

    8.5.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    8.5.4. Middle East and Africa

    8.5.4.1. Overview

    8.5.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    9. KEY VENDOR ANALYSIS

    9.1. Shire

    9.1.1. Company Overview

    9.1.2. SWOT Analysis

    9.1.3. Key Developments

    9.2. Octapharma

    9.2.1. Company Overview

    9.2.2. SWOT Analysis

    9.2.3. Key Developments

    9.3. CSL

    9.3.1. Company Overview

    9.3.2. SWOT Analysis

    9.3.3. Key Developments

    9.4. Grifols

    9.4.1. Company Overview

    9.4.2. SWOT Analysis

    9.4.3. Key Developments

    9.5. China Biologics Products, Inc.

    9.5.1. Company Overview

    9.5.2. SWOT Analysis

    9.5.3. Key Developments

    *Client can request additional company profiling as per specific requirements

    10. 360 DEGREE ANALYSTVIEW

    11. APPENDIX

    11.1. Research Methodology

    11.2. Abbreviations

    11.3. Disclaimer

    11.4. Contact Us

List Of Tables
in Intravenous Immunoglobulin Market, By Disease Types (CIDP, Hypogammaglobulinemia, Congenital AIDS, Immunodeficiency diseases, Chronic Lymphocytic Leukaemia, Myasthenia Gravis, Multifocal motor neuropathy, and others), By Route (Intravenous and Subcutaneous) And Geography (North America, Europe, Asia Pacific, And Rest Of The World) – Analysis, Share, Trends, Size, & Forecast From 2016 – 2027- C

List of Tables

Table 1 List of Acronyms

Table 2 Key Market Facts, 2016 – 2027

Table 3 Market Drivers: Impact Analysis

Table 4 Market Restraint: Impact Analysis

Table 5 Market Opportunity: Impact Analysis

Table 6 PESTLE Analysis

Table 7 Porter’s Five Forces Analysis

Table 8 Company Market Share Analysis

Table 9 Global Intravenous Immunoglobulin Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

Table 10 Intravenous Immunoglobulin Market, by Disease Types, 2016 – 2027 (USD Million)

Table 11 Intravenous Immunoglobulin Market, by Geography, 2016 – 2027 (USD Million)

Table 12 North America Intravenous Immunoglobulin Market, 2016 – 2027 (USD Million)

Table 13 U.S. Intravenous Immunoglobulin Market, 2016 – 2027 (USD Million)

Table 14 Canada Intravenous Immunoglobulin Market, 2016 – 2027 (USD Million)

Table 15 Europe Intravenous Immunoglobulin Market, 2016 – 2027 (USD Million)

Table 16 France Intravenous Immunoglobulin Market, 2016 – 2027 (USD Million)

Table 17 Germany Intravenous Immunoglobulin Market, 2016 – 2027 (USD Million)

Table 18 Asia Pacific Intravenous Immunoglobulin Market, 2016 – 2027 (USD Million)

Table 19 China Intravenous Immunoglobulin Market, 2016 – 2027 (USD Million)

Table 20 India Intravenous Immunoglobulin Market, 2016 – 2027 (USD Million)

Table 21 Latin America Intravenous Immunoglobulin Market, 2016 – 2027 (USD Million)

Table 22 MEA Intravenous Immunoglobulin Market, 2016 – 2027 (USD Million)

List Of Figures, Charts and Diagrams
in Intravenous Immunoglobulin Market, By Disease Types (CIDP, Hypogammaglobulinemia, Congenital AIDS, Immunodeficiency diseases, Chronic Lymphocytic Leukaemia, Myasthenia Gravis, Multifocal motor neuropathy, and others), By Route (Intravenous and Subcutaneous) And Geography (North America, Europe, Asia Pacific, And Rest Of The World) – Analysis, Share, Trends, Size, & Forecast From 2016 – 2027- C

List of Figures

Figure 1 Research Methodology

Figure 2 Research Process Flow Chart

Figure 3 Comparative Analysis, by Geography, 2016-2025 (Value %)

Figure 4 Regulatory Framework Analysis

Figure 5 Value Chain Analysis Analysis

Figure 6 Intravenous Immunoglobulin Market, by Disease Types, 2016 – 2027 (USD Million)

Figure 7 Intravenous Immunoglobulin Market, by Geography, 2016 – 2027 (USD Million)

Additional Details

Publisher

AnalystView

Publisher Information

AnalystView Market Insights is a market research and consulting firm that adopts a proactive approach to provide the diverse need for accurate and precise market research, custom research, and consulting solutions across geographies and industry verticals. Our company is led by a team of passionate, naturally curious, and strategic thinkers from different industry backgrounds.



These experts are dedicated to creating concrete market data analysis in various industries such as Healthcare, Bulk Chemicals, Semiconductors and Electronics, Foods and Beverages. We strive to develop meaningful and evidence-based research data that helps our clients, empowering organizations and brands of all sizes with strategic analysis, accurate data, and consumer trends.



We aim to be the number one choice for various clients who require credible data to make vital business decisions. We wish to be a trusted and reliable analytics partner to major business organizations.



We understand that critical business decisions can be taken only when verified, authentic information is available. Therefore, our experts work meticulously to provide our clients with the accurate data, so that they need not spend time in verifying it.



It is also our goal to help our clients ignore traditional research methods that require a large amount of capital, manpower, and most important of it all – the time. We know that these factors are precious to a company and always follow the latest research techniques that produce the required result in a short span of time.

Reference

270587 | AV147

Number of Pages

180

Report Format

PDF

AnalystView Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Peripheral Intravenous Catheter Market: Asia Pacific Regional Market to Witness the Fastest Growth Throughout the Forecast Period: Global Industry Analysis & Opportunity Assessment, 2016-2021
Peripheral intravenous catheter is a sophisticated medical device widely used to deliver certain flu...
27 Dec 2017 by Future Market Insights USD $5,000 More Info
Global Medical Intravenous Infusion Pump Market Research Report Forecast 2017 to 2021
The Global Medical Intravenous Infusion Pump Market Research Report Forecast 2017-2021 is a valuable...
28 Apr 2017 by S&P Consulting USD $2,800 More Info
Global Intravenous Needles Market Research Report Forecast 2017 to 2021
The Global Intravenous Needles Market Research Report Forecast 2017-2021 is a valuable source of ins...
28 Apr 2017 by S&P Consulting USD $2,800 More Info
Global Intravenous (IV) Iron Drugs Market Research Report Forecast 2017 to 2021
The Global Intravenous (IV) Iron Drugs Market Research Report Forecast 2017-2021 is a valuable sourc...
27 Apr 2017 by S&P Consulting USD $2,800 More Info
Global Intravenous Immunoglobulin (IVIg) Market Research Report Forecast 2017 to 2022
Delivery of the Report will take 2-3 working days once order is placed.The Global Intravenous Immuno...
26 Apr 2017 by S&P Consulting USD $2,800 More Info
Global Intravenous Fluid Containers Market Research Report Forecast 2017 to 2021
The Global Intravenous Fluid Containers Market Research Report Forecast 2017-2021 is a valuable sour...
26 Apr 2017 by S&P Consulting USD $2,800 More Info
Global Intravenous Immunoglobulin (IVIg) Market Research Report Forecast 2017 to 2021
The Global Intravenous Immunoglobulin (IVIg) Market Research Report Forecast 2017-2021 is a valuabl...
25 Apr 2017 by S&P Consulting USD $2,800 More Info
Global Disposable Intravenous Catheter Market Research Report Forecast 2017 to 2021
The Global Disposable Intravenous Catheter Market Research Report Forecast 2017-2021 is a valuable s...
25 Apr 2017 by S&P Consulting USD $2,800 More Info
Intravenous Solutions
Intravenous Solutions Market research report is analyzed by Type and Nutrients for each of the geogr...
01 Apr 2016 by USD $4,500 More Info
U.S. General Anesthesia Drugs Market by Molecule (Propofol, Benzodiazepines, ketamine(s(+) ketamine HCl), Methohexital Sodium), route of administration (Intravenous, Inhalational), Supply Chain (GPOs, Distributors), Competitive - Analysis Forecast to 2020
The report segments the U.S. general anesthesia drugs market on the basis of molecule and route of a...
24 Jul 2015 by MarketsandMarkets USD $5,650 More Info

This report is published by AnalystView

AnalystView Market Insights is a market research and consulting firm that adopts a proactive approach to provide the diverse need for accurate and precise market research, custom research, and consulting solutions across geographies and industry verticals. Our company is led by a team of passionate, naturally curious, and strategic thinkers from different industry backgrounds.

These experts are dedicated to creating concrete market data analysis in various industries such as Healthcare, Bulk Chemicals, Semiconductors and Electronics, Foods and Beverages. We strive to develop meaningful and evidence-based research data that helps our clients, empowering organizations and brands of all sizes with strategic analysis, accurate data, and consumer trends.

We aim to be the number one choice for various clients who require credible data to make vital business decisions. We wish to be a trusted and reliable analytics partner to major business organizations.

We understand that critical business decisions can be taken only when verified, authentic information is available. Therefore, our experts work meticulously to provide our clients with the accurate data, so that they need not spend time in verifying it.

It is also our goal to help our clients ignore traditional research methods that require a large amount of capital, manpower, and most important of it all – the time. We know that these factors are precious to a company and always follow the latest research techniques that produce the required result in a short span of time.

Download Free Report Summary PDF

Intravenous Immunoglobulin Market, By Disease Types (CIDP, Hypogammaglobulinemia, Congenital AIDS, Immunodeficiency diseases, Chronic Lymphocytic Leukaemia, Myasthenia Gravis, Multifocal motor neuropathy, and others), By Route (Intravenous and Subcutaneous) And Geography (North America, Europe, Asia Pacific, And Rest Of The World) – Analysis, Share, Trends, Size, & Forecast From 2016 – 2027- C | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...